BioAtla Inc (BCAB)
2.91
-0.22
(-7.03%)
USD |
NASDAQ |
May 09, 11:50
BioAtla Shareholders Equity (Quarterly): 70.67M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 70.67M |
| September 30, 2023 | 94.70M |
| June 30, 2023 | 124.52M |
| March 31, 2023 | 156.43M |
| December 31, 2022 | 180.34M |
| September 30, 2022 | 142.63M |
| June 30, 2022 | 164.95M |
| March 31, 2022 | 190.05M |
| Date | Value |
|---|---|
| December 31, 2021 | 210.82M |
| September 30, 2021 | 230.65M |
| June 30, 2021 | 178.02M |
| March 31, 2021 | 195.92M |
| December 31, 2020 | 209.97M |
| September 30, 2020 | -74.52M |
| December 31, 2019 | -55.96M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-74.52M
Minimum
Sep 2020
230.65M
Maximum
Sep 2021
134.61M
Average
164.95M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Marinus Pharmaceuticals Inc | 16.76M |
| Equillium Inc | 22.57M |
| Poseida Therapeutics Inc | 103.70M |
| Biomea Fusion Inc | 135.31M |
| Candel Therapeutics Inc | 12.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 119.66M |
| Total Liabilities (Quarterly) | 48.99M |